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INTRODUCTION
Radiotherapy is one of the most widely used cancer treat-
ment modalities [1]. Its primary goal is to shrink tumors and
kill cancer cells without permanently damaging the surround-
ing healthy tissue. This is managed by carefully manipulating
dose profiles and delivery schedules, and by boosting can-
cer cell death using radiosensitizers [2]. Studies have con-
firmed that tumor heating changes several critical parameters
within the tumor microenvironment. Specifically, hyperther-
mia enhances vascular perfusion and oxygenation state [1].
Moreover, it inhibits the repair of DNA [1]. Hyperthermia is,
therefore, an excellent radiosensitizer and makes tumors more
susceptible to death through radiation [3]. Therapies such as
combined-hyperthermia-radiotherapy (CHR) make use of this,
requiring treatment of tumors with heat and radiation. Several
phase III clinical trials for cervical cancer, superficial breast
cancer, malignant metastatic melanoma, head and neck cancer,
and glioma have demonstrated significant benefits of using
hyperthermia in combination with radiotherapy [1].
Mathematical tumor response modeling is increasingly
being recognized as one of the most effective tools to provide
insights on dose administration [4]. While there are several
single-physics models describing radiotherapy and tumor re-
sponse [5, 6, 7, 8], few models consider the interdependence
of the physics involved. To appropriately model a CHR treat-
ment, features like tumor heating (heat transfer), dosimetry
(radiation transport), and tumor dynamics (cell population
dynamics) need to be considered together. Our first paper
on modeling such treatments introduced a one-way coupled
model that could only account for isotropic scattering [9]. In
the present work, we extend our transport model to incorporate
anisotropic scattering. We note that this is not an exhaustive
study; in particular, the test problem discussed here does not
model a real-world treatment scenario.
The remainder of this paper is organized as follows. The
governing equations and relevant physics are introduced in the
next section. Subsequently, we describe a test problem and
present numerical results. We discuss our conclusions in the
final section.
GOVERNING EQUATIONS
Our CHR model is driven by three main physics: 1) ra-
diation transport to model internal dosimetry, 2) heat transfer
to incorporate the effects of tumor heating, and 3) cell popu-
lation dynamics to determine how the tumor responds to the
combination treatment. In this work, we consider a simple
model that is is one-dimensional in space, monoenergetic, and
accomodates anisotropic radiation sources and scattering.
Radiation Transport and Dosimetry
The standard Boltzmann transport equation [10] ade-
quately models transport in problems with forward-peaked
scattering. However, sometimes, prohibitively large Leg-
endre expansion orders are required to accurately represent
anisotropic kernels [11]. In order to overcome this limitation,
the scattering term is broken into smooth and singular compo-
nents [12]. Such decomposition of the transport equation leads
to the Boltzmann-Fokker-Planck (BFP) approximation. We
use the following monoenergetic Boltzmann-Fokker-Planck
equation to model the flux distribution [12]:
1
v
∂ψ
∂t
+ µ
∂ψ
∂x
+ σt(x)ψ =
L−2∑
l=0
2l + 1
2
Pl(µ)σ˜s,lφl
+
σtr
2
∂
∂µ
(1 − µ2)∂ψ
∂µ
+ Q(x, µ, t),
(1a)
ψ(0.µ, t) = a(µ, t) for µ > 0, (1b)
ψ(X, µ, t) = b(µ, t) for µ < 0, (1c)
where ψ = ψ(x, µ, t) represents the angular flux in terms of
position x, direction µ, and time t; v is the photon velocity;
φ is the scalar flux; σt is the total macroscopic cross-section;
L is the Legendre expansion order for scattering; a and b are
the prescribed boundary conditions; and Q is an anisotropic
source. Moreover, σ˜s,l represents the lth moment of the smooth
component of the scattering cross-section σs. The Legendre
moments of the scattering cross-section are represented by
σs,l. The moments smooth component of the scattering cross-
section is written as [12]:
σ˜s,l = σs,l − σs,L = σtr2 [L(L + 1) − l(l + 1)] ,
l = 0, 1...L − 2.
(2)
The momentum transfer σtr is represented as:
σtr =
σs,L−1 − σs,L
L
. (3)
We use the following Henyey-Greenstein kernel to represent
the anisotropic scattering:
f (µ) =
1 − g2
2(1 + g2 − 2gµ)3/2 , (4)
where f is the phase function used to represent scattering and
g is the anisotropy factor. The moments of this phase function
are [13]:
fl = gl. (5)
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We calculate the dose using the following equations [14]:
D(x, t) =
(
µen
ρ
)
Φ(x, t)E, (6a)
Φ(x, t) =
∫ t
0
dt′φ(x, t′). (6b)
Here, D represents the dose; µen
ρ
is the mass energy absorption
coefficient; E is the energy per photon; and Φ is the fluence
at time t. The effective dose DE is evaluated using the linear-
quadratic model [1]:
DE(x, t) = αD(x, t) + βD2(x, t), (7)
where α and β are radiobiology parameters that determine
relative contribution of each term in the sum toward the total
radiation effect [1].
Hyperthermia and Heat Transfer
Recently, there has been an increase in the use of thermal
medicine for cancer care. Novel techniques, including ra-
diofrequency and ultrasound ablation, have been developed in
order to induce hyperthermia inside tumors [1]. Although the
use of a more sophisticated heat transport model is warranted,
here we use simple heat conduction to model hyperthermia
[15]:
ρcp
∂T (x, t)
∂t
=
∂
∂x
κ
∂T (x, t)
∂x
+ q(x), (8)
where cp, ρ, and κ are respectively the specific heat capacity,
the material density, and the thermal conductivity of tissue
(assumed constant), and q is the volumetric heat source.
Cell Survival and Radiosensitivity Parameter
The cell survival probability S is chosen in such a way
that a larger dose results in smaller survival probability, as
given by [8]:
S (x, t) = e−DE (x,t). (9)
In order to incorporate heat effects, we use the radiosensi-
tivity parameter [9] ξ. We define this parameter as the ratio of
the biological damage caused by a given amount of radiation
dose to tissue with and without heating. We represent this
damage (cell kill) as RCHR and RRT respectively:
RRT = 1 − S , (10a)
RCHR = ξ(1 − S ). (10b)
At normal body temperature, ξ = 1 irrespective of time. We
also set ξ at time zero to be unity. We arbitrarily assume
ξ = 2.5 for our system when the tumor is heated to an average
temperature Tavg of 45◦C over 30 minutes. In order to define
ξ elsewhere, we employ bilinear interpolation [16] between
the data points ξ(37, 0) = 1, ξ(37, 30) = 1, ξ(45, 0) = 1 and
ξ(45, 30) = 2.5. This returns:
ξ(Tavg, t) = 1 − 0.23125Tavg + 0.00625(Tavg × t). (11)
Cell Population Dynamics
Traditionally, the tumor dynamics are determined accord-
ing to three factors: proliferation, invasion, and cell kill in-
duced by treatment [8]. Proliferation determines the balance
between cell division and cell loss due to natural death; in-
vasion determines the transport of tumor cells in the area of
interest; and the cell kill incorporates the effects of treatment
on tumors. The following balance equation determines tumor
cell concentration, c(x, t), over time [8]:
∂c
∂t
=
∂
∂x
(
I
∂c
∂x
)
+ pc(x, t) − R(x, t)c(x, t). (12)
Here, the diffusion coefficient I represents motility of tumor
cells, and p is the proliferation rate. Patient-specific invasion
and proliferation rates can be obtained using MRI images [8].
This preliminary model is heavily simplified and does not
currently consider temperature-dependent cross-sections for
transport, material density changes, and decay heat. These
simplifications allow us to get a one-way coupled system. We
plan to eliminate these assumptions and model this system
with a fully-coupled framework in a later paper.
CHRModel
The tumor response over time is determined using the
equations presented in the previous section. The coupling and
solution can be represented via the following Newton step:
Jφφ 0 0 0 0
JφDE JDEDE 0 0 0
0 0 JTT 0 0
0 JDER JTR JRR 0
0 0 0 JRc Jcc


δφ
δDE
δT
δR
δc
 = −

Fφ
FDE
FT
FR
Fc
 ,
(13)
where Fφ, FDE , FT , FR, and Fc are the residual forms of the
relevant equations for flux, effective dose, temperature, effect
of therapy on cell kill, and tumor cell concentration.
Since the Jacobian matrix above is not block-diagonal,
the physics are interrelated. The lower-triangular structure of
the Jacobian matrix suggests one-way coupling. Therefore,
we solve the problem in a serial fashion. First, we solve the
BFP equation to determine flux. Subsequently, fluence, dose,
effective dose, and the survival probability (in that order) are
evaluated. Next, we solve the heat equation to determine the
temperature, and then evaluate the heating-adjusted effect of
radiation on tissue. Finally, the tumor cell concentration is
evaluated. This kind of modeling allows us to continuously
track tumor cell density over time.
We discretize the BFP equation using the standard back-
ward Euler method in time and diamond-difference/discrete
ordinates scheme in space/angle. The angular Laplacian uses
Morel’s weighted finite difference scheme [17]. The heat
transfer and the cell population dynamics equations employ
backward Euler and central finite difference for time/space
discretization. These schemes are well-known and therefore
are not discussed here in detail.
NUMERICAL RESULTS AND DISCUSSION
We consider the evolution of tumor-cell concentration dis-
tribution in a three-region slab over a period of thirty minutes.
The first and the third regions, each 1.4 cm thick, represent
healthy soft-tissue. The second soft-tissue region (in the mid-
dle) is 0.2 cm thick, and has uniformly distributed tumor cells
with a concentration of 220 cellscm3 . Moreover, in order to in-
duce hyperthermia, this region also has a constant volumetric
heat source. We introduce radiation to this system through a
time-dependent beam of 0.4 MeV photons throught the left
boundary along the most forward discrete direction µN ; that
is:
ψ(0, µ, t) = a(µ, t) =
{
5.6 × 105e−ηt, if µ = µN ,
0, otherwise . (14)
Here, η is 75 days. We also assume a vacuum right boundary
such that ψ(X.µ, t) = b(µ, t) = 0, with X = 3 cm.
The heat source is q = 13
W
cm3 . Both the heat transfer
and tumor dynamics equations have open boundaries. We
assume the parameters presented in Table I [8, 18]. We follow
existing literature and assume similar continuum properties
for both healthy and tumor tissue [8]. The relevant cross-
section moments are presented in Table II. For each of the
test problems, we choose a uniform time step of ∆t = 0.025
s and 270 spatial cells. We set the angular discretization
for the transport equation to twelve angles. We assume an
anisotropy factor of g = 0.9. The BFP equation is solved using
the standard source iteration method, and the heat and tumor
dynamics equations are solved using MATLAB’s backslash
function [19].
Test Problem
First, we analyze the estimates for the final tumor cell
concentration when using different models for transport (with
a highly anisotropic beam source). We compare three trans-
port models: 1) transport equation with isotropic scattering;
2) transport equation with anisotropic scattering with a trun-
cated scattering expansion order; and 3) BFP equation. Fig-
ure 1 plots tumor cell concentration at the center-most node
of the spatial grid over time. We note that both isotropic and
anisotropic transport with a truncated scattering term underes-
timate tumor cell population over time. This can be attributed
to the fact that both these models do not represent scattering
adequately. Therefore, these models do not accurately model
(overestimate) flux evolution over time. This results in an
underestimation of tumor cell concentration.
Next, we consider tumor dynamics in three scenarios:
1) untreated tissue (no radiation or heat source), 2) tumor
undergoing stand-alone radiotherapy, and 3) tumor combined-
hyperthermia. We maintain the same heat and radiation
sources in our system for the relevant physics. We model
transport using the BFP equation. Figure 2 shows that the
radiation beam begins to kill cancer cells and reduces the total
tumor cell concentration at the end of thirty minutes. We also
observe that hyperthermia enhances the cell kill; this is evident
from the further reduction in tumor cell concentration.
CONCLUSIONS
We extended our CHR model to incorporate anisotropic
transport. We compared different transport models and ob-
served that the use of both isotropic and prematurely truncated
anisotropic transport equations result in underestimation of the
Fig. 1. Tumor Cell Concentration Comparison
Fig. 2. Treatment Comparison
overall tumor cell concentration. The introduction of radiation
results in significant cell kill. Moreover, introduction of heat
enhances radiosensitivity of the tumor cells, which increases
the cell kill. We plan to extend our model in subsequent papers
such that real-world treatments can be addressed. We also plan
to extend this model to address random tumor media. This
will form a major portion of our work in CHR modeling.
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TABLE I. Parameters
I p α α
β
κ cp ρ
µen
ρ
[mm/yr] [/yr] [kg/J] [J/kg] [W/m.K] [kJ/kg.K] [g/cc] [cm2/g]
4.29 35.13 0.203 10 0.51 3.68 1.0 0.0325
TABLE II. Scattering Cross-section Moments
Moment Value Moment Value
σt 0.1053578 σtr 0.000333856436591749
σs,0 0.105324 σ˜s,0 0.050237687962361
σs,1 0.0947916 σ˜s,1 0.040039144398953
σs,2 0.08531244 σ˜s,2 0.031227697272137
σs,3 0.076781196 σ˜s,3 0.023698022581912
σs,4 0.0691030764 σ˜s,4 0.017355328728279
σs,5 0.06219276876 σ˜s,5 0.012114303271238
σs,6 0.055973491884 σ˜s,6 0.007898165014788
σs,7 0.0503761426956 σ˜s,7 0.004637810882530
σs,8 0.04533852842604 σ˜s,8 0.002271048105704
σs,9 0.040804675583436 σ˜s,9 0.000741903192426
σs,10 0.036724208025092 σ˜s,10 0
σs,11 0.033051787222583 σ˜s,11 0
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